Age-associated alterations in cholesterol homeostasis: Evidence from a cross-sectional study in a Northern Italy population

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 425-432

  Bertolotti, Marco ^a   Mussi, Chiara ^a   Pellegrini, Elisa ^a   Magni, Alessandro ^b   Del Puppo, Marina ^b   Ognibene, Silvia ^a   Carulli, Lucia ^a   Anzivino, Claudia ^a   Baldelli, Enrica ^a   Loria, Paola ^a   Carulli, Nicola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Aging; Cardiovascular risk; Cholesterol metabolism; Cholesterol synthesis; Gallstone disease

Indexed keywords

7 ALPHA HYDROXY 4 CHOLESTEN 3 ONE; BIOLOGICAL MARKER; CAMPESTEROL; CHOLESTEROL; LATHOSTEROL; SITOSTEROL; UNCLASSIFIED DRUG; 7 ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; CHOLEST 4 EN 3 ONE; GAMMA-SITOSTEROL; PHYTOSTEROL; SITOSTEROL DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GALLSTONE; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; ITALY; LIPID ABSORPTION; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; SEX DIFFERENCE; VERY ELDERLY; AGE; ANALOGS AND DERIVATIVES; BLOOD; EPIDEMIOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGE FACTORS; AGED; AGING; CHOLESTENONES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GALLSTONES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HOMEOSTASIS; HUMANS; ITALY; MALE; MIDDLE AGED; PHYTOSTEROLS; SITOSTEROLS;

EID: 84897874947     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s57714     Document Type: Article

References (40)

1. Wilson P W, Anderson KM, Harris T, Kannel WB, Castelli W P. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252-M257.
2. Aronow WS. Lipids in the elderly. Rev Endocr Metab Dis. 2004;5: 359-364.
3. Grundy SM, Cleeman JI, Rifkind BM, Kuller LH. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Arch Intern Med. 1999;159: 1670-1678.
4. Lemaitre RN, Psaty BM, Heckbert SR, Kronmal RA, Newman AB, Burke GL. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. Arch Intern Med. 2002;162:1395-1400.
5. Grundy SM. Statin therapy in older persons. Pertinent issues. Arch Intern Med. 2004;162:1329-1331.
6. Ali R, Alexander K P. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Am J Geriatr Pharmacother. 2007;5:52-63.
7. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology. 1997;26:809-818.
8. Bertolotti M, Gabbi C, Anzivino C, Carulli L, Carulli N. Changes in bile acid synthesis in gallstone disease: cause, consequence, or neither? Hepatology. 2007; 46:1664; 1664-1665.
9. Bertolotti M, Gabbi C, Anzivino C, Carulli L, Loria P, Carulli N. Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insight from evidence on hepatic cholesterol degradation and gallstone disease in humans. Curr Med Chem. 2008;15: 2271-2284.
10. Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest. 1991;87:591-596.
11. Einarsson K, Nilsell K, Leijd B, Angelin B. Infuence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Eng J Med. 1985;313:277-282.
12. Bertolotti M, Abate N, Bertolotti S, et al. Effect of aging on cholesterol 7 alpha-hydroxylation in humans. J Lipid Res. 1993;34:1001-1007.
13. Bertolotti M, Gabbi C, Anzivino C, et al. Age-related changes in bile acid synthesis and hepatic nuclear receptor expression. Eur J Clin Invest. 2007;37:501-508.
14. Carulli N, Ponz de Leon M, Zironi F, et al. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short-term feeding of chenodeoxycholic and ursodeoxycholic acid. J Lipid Res. 1980;21:35-43.
15. Reihnér E, Angelin B, Björkhem I, Einarsson K. Hepatic cholesterol metabolism in cholesterol gallstone disease. J Lipid Res. 1991;32: 469-475.
16. Attili AF, Carulli N, Roda E, et al. Epidemiology of gallstone disease in Italy: prevalence data of the multicenter Italian study on cholelithiasis (MICOL). Am J Epidemiol. 1995;141:158-165.
17. Festi D, Dormi A, Capodicasa S, et al. Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol. 2008;14:5282-5289.
18. Del Puppo M, Kienle MG, Petroni ML, Crosignani A, Podda M. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. J Lipid Res. 1998;39:2477-2482.
19. Bertolotti M, Del Puppo M, Gabbi C, et al. Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients. Steroids. 2008;73:1197-1202.
20. Kempen HJ, Glatz JF, Gevers Leuven JA, Van Der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res. 1988;29:1149-1155.
21. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20-31.
22. Axelson M, Aly A, Sjövall J. Levels of 7alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett. 1988;239:324-328.
23. Gälman C, Angelin B, Rudling M. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med. 2011;270: 580-588.
24. Tilvis RS, Valvanne JN, Strandberg TE, Miettinen TA. Prognostic significance of serum cholesterol, lathosterol, and sitosterol in old age; a 17-year population study. Ann Med. 2011;43:292-301.
25. Dietschy JM, Turley SD, Spady DK. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res. 1993;34:1637-1659.
26. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125-1131.
27. Pallottini V, Martini C, Cavallini G, et al. Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia. J Cell Biochem. 2006;98:1044-1053.
28. Hotta K, Bodkin NL, Gustafson TA, Yoshioka S, Ortmeyer HK, Hansen BC. Age-related adipose tissue mRNA expression of ADD1/ SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in Rhesus monkeys. J Gerontol A Biol Sci Med Sci. 1999;54: B183-B188.
29. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368:230-239.
30. Loria P, Carulli N, Medici G, et al. Effect of ursocholic acid on bile lipid secretion and composition. Gastroenterology. 1986;90:865-874.
31. Muhrbeck O, Wang FH, Björkhem I, Axelson M, Einarsson K. Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects. J Hepatol. 1997;27: 150-155.
32. Gälman C, Miquel JF, Pérez RM, et al. Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. Gastroenterology. 2004;126:741-748.
33. Aronow WS. Management of hyperlipidemia with statins in the older patient. Clin Interv Aging. 2006;1:433-438.
34. Szadkowska I, Stanczyk A, Aronow W, et al. Statin therapy in the elderly: a review. Arch Gerontol Geriatr. 2010;50:114-118.
35. Karlamangla AS, Singer BH, Reuben DB, Seeman TE. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging. J Am Geriatr Soc. 2004;52:487-494.
36. Newson RS, Felix J F, Heeringa J, Hofman A, Witteman JC, Tiemeier H. Association between serum cholesterol and noncardiovascular mortality in older age. J Am Geriatr Soc. 2011;59:1779-1785.
37. Corti MC, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997;126:753-760.
38. Zuliani G, Cavalieri M, Galvani M, et al. Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. J Gerontol A Biol Sci Med Sci. 2010;65(5): 559-564.
39. Vigna GB, Zuliani G, Fellin R. Dyslipidemias in the older subject: features, significance and treatment dilemmas. Clin Lipidol. 2011;6: 339-350.
40. Lupattelli G, Siepi D, De Vuono S, et al. Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia. Life Sci. 2012;90:846-850.